Are There Any Emerging Anticonvulsants for Cancer Care?
Research is ongoing to identify new anticonvulsants with better efficacy and fewer side effects. Some newer agents showing promise include lacosamide and brivaracetam, which offer advantages like fewer drug interactions and improved tolerability. Clinical trials are essential to establish their role in cancer care.